Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print April 30, 2008, doi:10.1212/01.wnl.0000303960.01039.43)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
01.wnl.0000303960.01039.43v1
70/23/2201    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Kinkingnéhun, S.
Right arrow Articles by Dubois, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinkingnéhun, S.
Right arrow Articles by Dubois, B.
Received January 30, 2007
Accepted October 22, 2007

VBM anticipates the rate of progression of Alzheimer disease. A 3-year longitudinal study

S. Kinkingnéhun PhD, M. Sarazin MD, PhD*, S. Lehéricy MD, PhD, E. Guichart-Gomez , T. Hergueta , and B. Dubois MD

From INSERM U610 (S.K., M.S., S.L., B.D.), Paris; IFR-49 (S.K., S.L.), SHFJ, Orsay; e(ye)BRAIN (S.K.), Paris; Research and Resource Memory Centre (M.S., E.G.-G., T.H., B.D.), Service de Neuroradiologie (S.L.), and IFR-70 (B.D.), Groupe Hospitalier Pitié-Salpêtrière, Paris; Center for NeuroImaging Research–CENIR (S.L.), Paris; and Université Pierre et Marie Curie-Paris 6 (S.L., B.D.), Paris, France.


* To whom correspondence should be addressed. E-mail: marie.sarazin{at}psl.aphp.fr.

Objective: To determine whether regional atrophy or neuropsychological factors can predict the rate of decline in patients with mild Alzheimer disease (AD).

Background: Despite important implications for planning the care and treatment strategy, few prognostic factors of severe AD progression are known.

Methods: Twenty-three patients with mild AD were followed up every 6 months over the course of 3 years. At baseline, patients with AD and 18 controls underwent a neuropsychological battery and a brain MRI. At the end of the 3 years, patients with AD were dichotomized into slow decliners (SLD) or fast decliners (FD) groups on the basis of their decline in Mini-Mental State Examination score over time. We compared baseline cognitive performance and imaging data using voxel-based morphometry (VBM).

Results: SLD and FD groups did not differ in age, gender, level of education, mean estimated duration of illness, and standard neuropsychological data at inclusion, except for the Attentional Battery of the Cambridge Neuropsychological Tests Automated Battery (speed processing in shifting condition). VBM comparison between SLD and FD groups demonstrated more gray matter tissue loss in the FD group in the medial occipitoparietal areas, especially in the precuneus, the lingual gyrus, the cuneus, and the surrounding cortex of the parieto-occipital sulcus bilaterally.

Conclusion: Voxel-based morphometry analysis demonstrated that patients who will have a faster decline at 3 years already had a more extensive cortical atrophy than SLD patients, especially in the medial occipitoparietal areas, which was not yet detected by clinical and neuropsychological assessment.




This article has been cited by other articles:


Home page
NeurologyHome page
G. B. Frisoni and J. L. Whitwell
How fast will it go, doc?: New tools for an old question from patients with Alzheimer disease
Neurology, June 3, 2008; 70(23): 2194 - 2195.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by AAN Enterprises, Inc.